Literature DB >> 32620433

Clinical Management of Exercise-Induced Anaphylaxis and Cholinergic Urticaria.

Mario Geller1.   

Abstract

Exercising is both pleasant and healthy. In some individuals, it can trigger adverse reactions. Examples of these reactions include exercise-induced anaphylaxis (EIA) and cholinergic urticaria (ChoIU). EIA presents as food-associated and non-food-associated conditions. Strenuous exertion may provoke both EIA and ChoIU, but with exercise the passive warming will induce solely ChoIU and not EIA. The morphologic size of the urticarial wheals can help distinguish between these 2 types of conditions. Small punctate wheals are present in ChoIU and large ones in EIA. Wheat is the most common food associated with food-dependent exercise-induced anaphylaxis and gluten is its most important antigen. Omega-5-gliadin is the major epitope of gluten. The most common medicines associated with drug-dependent exercise-induced anaphylaxis are the nonsteroidal anti-inflammatory drugs including aspirin.
Copyright © 2020 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anaphylaxis; Cholinergic urticaria; Cotriggers; Drug-dependence; Exercise; Food-dependence; Food-independence; Inducible urticarias; Physical tolerance; Triggers

Mesh:

Substances:

Year:  2020        PMID: 32620433     DOI: 10.1016/j.jaip.2020.01.025

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  3 in total

Review 1.  Fatal Anaphylaxis: Epidemiology and Risk Factors.

Authors:  Irene Mikhail; David R Stukus; Benjamin T Prince
Journal:  Curr Allergy Asthma Rep       Date:  2021-04-07       Impact factor: 4.806

2.  Exercise-Induced Urticaria: A Rare Case Report.

Authors:  Nikita Sijapati; Monica Sciturro; Matthew Le; Jesus Lanza; Edgar Mercado; Admir Seferovic
Journal:  Cureus       Date:  2022-03-11

Review 3.  Cholinergic Urticaria: Subtype Classification and Clinical Approach.

Authors:  Atsushi Fukunaga; Yoshiko Oda; Shinya Imamura; Mayuko Mizuno; Takeshi Fukumoto; Ken Washio
Journal:  Am J Clin Dermatol       Date:  2022-09-15       Impact factor: 6.233

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.